Use of differentiated pluripotent stem cells in replacement therapy for treating disease

See allHide authors and affiliations

Science  22 Aug 2014:
Vol. 345, Issue 6199, 1247391
DOI: 10.1126/science.1247391

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Challenges for stem cell–based therapies

Patient-derived pluripotent stem cells (PSCs) hold promise in the treatment of injury and disease. An ever-increasing number of specific cell types can be generated from PSCs, but technical challenges remain in applying these cells in the clinic. Fox et al. review the challenges in attaining this goal. These include gene modification, cell rejection, and delivery and localization issues involved in transplantation of cells for the treatment of diabetes and disorders of the blood, liver, heart, and brain.

Science, this issue 10.1126/science.1247391